Why this matters Taxes shape the final price patients and consumers pay at the counter. New York’s 2024–2025 changes lowered the tax burden on medical cannabis and simplified adult-use taxes—two shifts that can influence affordability in different ways. The medical...
Why you’re hearing so much about Delta-8 Delta-8 THC (usually converted from hemp-derived CBD) remains in legal limbo. In 2025, the FDA continued issuing warning letters over safety/labeling violations, while many states moved to restrict or ban intoxicating hemp...
The headline A new peer-reviewed study following patients with primary insomnia for up to 18 months found sustained improvements in subjective sleep quality and health-related quality of life among those prescribed cannabis-based medicinal products. But it’s an...
The U.S. Department of Justice has proposed moving cannabis from Schedule I to Schedule III. If finalized, this would not legalize adult-use federally—but it would likely remove the punishing 280E tax burden going forward and could gradually lower patient costs in New...
1. The 2.5 mg Revolution “Less is more” isn’t just a wellness meme—it’s the medical-cannabis headline of 2025. Google search interest in microdosing cannabis skyrocketed 1,250 % between 2015 and 2023 and has kept climbing as Schedule III rescheduling inches closer to...
